Related references
Note: Only part of the references are listed.Abacavir Use and Risk of Acute Myocardial Infarction and Cerebrovascular Events in the Highly Active Antiretroviral Therapy Era
Roger J. Bedimo et al.
CLINICAL INFECTIOUS DISEASES (2011)
No Risk of Myocardial Infarction Associated With Initial Antiretroviral Treatment Containing Abacavir: Short and Long-Term Results from ACTG A5001/ALLRT
Heather J. Ribaudo et al.
CLINICAL INFECTIOUS DISEASES (2011)
Methodological Concerns and Quality Appraisal of Contemporary Systematic Reviews and Meta-Analyses in Pediatric Urology
Luis H. Braga et al.
JOURNAL OF UROLOGY (2011)
Impact of Individual Antiretroviral Drugs on the Risk of Myocardial Infarction in Human Immunodeficiency Virus-Infected Patients A Case-Control Study Nested Within the French Hospital Database on HIV ANRS Cohort CO4
Sylvie Lang et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Analysis of serious non-AIDS events among HIV-infected adults at Latin American sites
W. H. Belloso et al.
HIV MEDICINE (2010)
Abacavir and risk of myocardial infarction in HIV-infected patients on highly active antiretroviral therapy: a population-based nationwide cohort study
N. Obel et al.
HIV MEDICINE (2010)
Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study
Signe Westring Worm et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Cerebrovascular Ischemic Events in HIV-1-Infected Patients Receiving Highly Active Antiretroviral Therapy: Incidence and Risk Factors
Inigo Corral et al.
CEREBROVASCULAR DISEASES (2009)
Simplification of Antiretroviral Therapy with Tenofovir-Emtricitabine or Abacavir-Lamivudine: A Randomized, 96-Week Trial
Allison Martin et al.
CLINICAL INFECTIOUS DISEASES (2009)
Risk of Myocardial Infarction and Abacavir Therapy: No Increased Risk Across 52 GlaxoSmithKline-Sponsored Clinical Trials in Adult Subjects
Cindy H. Brothers et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients
Jens D. Lundgren et al.
AIDS (2008)
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study:: a multi-cohort collaboration
Caroline A. Sabin et al.
LANCET (2008)
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies
LANCET (2008)
Performance of propensity score calibration- : A simulation study
Til Sturmer et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Class of antiretroviral drugs and the risk of myocardial infarction
Nina Friis-Moller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews
Beverley J. Shea et al.
BMC MEDICAL RESEARCH METHODOLOGY (2007)
Protease inhibitors and cardiovascular disease: analysis of the Los Angeles County adult spectrum of disease cohort
G. Vaughn et al.
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV (2007)
Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use
Grace P. S. Kwong et al.
AIDS (2006)
Instruments for causal inference -: An epidemiologist's dream?
MA Hernán et al.
EPIDEMIOLOGY (2006)
Adjusting effect estimates for unmeasured confounding with validation data using propensity score calibration
T Stürmer et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2005)
Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patients
UH Iloeje et al.
HIV MEDICINE (2005)
Medical progress - Cardiovascular risk and body-fat abnormalities in HIV-infected adults.
S Grinspoon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Risk factors for myocardial infarction in HIV-positive patients
E Quiros-Roldan et al.
INTERNATIONAL JOURNAL OF STD & AIDS (2005)
Cardio- and cerebrovascular events in HIV-infected persons
AD Monforte et al.
AIDS (2004)
Combination antiretroviral therapy and the risk of myocardial infarction
N Friis-Moller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
An open-label, prospective, observational study of the incidence of coronary artery disease in patients with HIV infection receiving highly active antiretroviral therapy
G Barbaro et al.
CLINICAL THERAPEUTICS (2003)
Incidence of myocardial infarction in randomized clinical trials of protease inhibitor-based antiretroviral therapy: An analysis of four different protease inhibitors
PM Coplan et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2003)
Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection
SA Bozzette et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?
D Klein et al.
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2002)
Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures
MA Hernán et al.
STATISTICS IN MEDICINE (2002)
Ischemic cardiovascular disease in persons with human immunodeficiency virus infection
MH David et al.
CLINICAL INFECTIOUS DISEASES (2002)
Marginal structural models to estimate the joint causal effect of nonrandomized treatments
MA Hernán et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2001)
Marginal structural models and causal inference in epidemiology
JM Robins et al.
EPIDEMIOLOGY (2000)
Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men
MA Hernan et al.
EPIDEMIOLOGY (2000)
Share Paper
